메뉴 건너뛰기




Volumn , Issue , 2012, Pages 77-83

Rule-based whole body modeling for analyzing multi-compound effects

Author keywords

Combination drug; Drug effect; Multi scale modeling; Rule based simulation; Type 2 Diabetes; Whole body simulation

Indexed keywords

COMBINATION DRUG; DRUG EFFECTS; MULTI-SCALE MODELING; RULE BASED; TYPE-2 DIABETES; WHOLE-BODY;

EID: 84870480720     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1145/2390068.2390083     Document Type: Conference Paper
Times cited : (1)

References (24)
  • 1
    • 35148824614 scopus 로고    scopus 로고
    • Network pharmacology
    • (Oct),. DOI= http://dx.doi.org/10.1038/nbt1007-1110
    • HOPKINS, A.L., 2007. Network pharmacology. Nat Biotechnol 25, 10 (Oct), 1110-1111. DOI= http://dx.doi.org/10.1038/nbt1007-1110.
    • (2007) Nat Biotechnol , vol.25 , Issue.10 , pp. 1110-1111
    • Hopkins, A.L.1
  • 2
    • 60449115552 scopus 로고    scopus 로고
    • The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions
    • Mar
    • LU, L., PAYVANDI, F., WU, L., ZHANG, L.H., HARIRI, R.J., MAN, H.W., CHEN, R.S., MULLER, G.W., HUGHES, C.C., STIRLING, D.I., SCHAFER, P.H., and BARTLETT, J.B., 2009. The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions. Microvasc Res 77, 2 (Mar), 78-86. DOI= http://dx.doi.org/10.1016/j.mvr.2008.08.003.
    • (2009) Microvasc Res , vol.77 , Issue.2 , pp. 78-86
    • U, L.L.1    Payvandi, F.2    U, L.W.3    Zhang, L.H.4    Hariri, R.J.5    Man, H.W.6    Chen, R.S.7    Muller, G.W.8    Hughes, C.C.9    Stirling, D.I.10    Schafer, P.H.11    Bartlett, J.B.12
  • 3
    • 67049100457 scopus 로고    scopus 로고
    • Drug discovery using chemical systems biology: Identification of the proteinligand binding network to explain the side effects of CETP inhibitors
    • May
    • XIE, L., LI, J., and BOURNE, P.E., 2009. Drug discovery using chemical systems biology: identification of the proteinligand binding network to explain the side effects of CETP inhibitors. PLoS Comput Biol 5, 5 (May), e1000387. DOI= http://dx.doi.org/10.1371/journal.pcbi.1000387.
    • (2009) PLoS Comput Biol , vol.5 , Issue.5
    • Xie, L.1    I, J.L.2    Bourne, P.E.3
  • 5
    • 33847377573 scopus 로고    scopus 로고
    • A robustness-based approach to systemsoriented drug design
    • Mar
    • KITANO, H., 2007. A robustness-based approach to systemsoriented drug design. Nat Rev Drug Discov 6, 3 (Mar), 202-210. DOI= http://dx.doi.org/10.1038/ nrd2195.
    • (2007) Nat Rev Drug Discov , vol.6 , Issue.3 , pp. 202-210
    • Kitano, H.1
  • 6
    • 54249155522 scopus 로고    scopus 로고
    • Network pharmacology: The next paradigm in drug discovery
    • Nov
    • HOPKINS, A.L., 2008. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4, 11 (Nov), 682-690. DOI= http://dx.doi.org/10.1038/ nchembio.118.
    • (2008) Nat Chem Biol , vol.4 , Issue.11 , pp. 682-690
    • Hopkins, A.L.1
  • 7
    • 33749011163 scopus 로고    scopus 로고
    • The NCI60 human tumour cell line anticancer drug screen
    • Oct
    • SHOEMAKER, R.H., 2006. The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer 6, 10 (Oct), 813-823. DOI= http://dx.doi.org/10.1038/ nrc1951.
    • (2006) Nat Rev Cancer , vol.6 , Issue.10 , pp. 813-823
    • Shoemaker, R.H.1
  • 8
    • 70049113642 scopus 로고    scopus 로고
    • Optimal drug combinations and minimal hitting sets
    • VAZQUEZ, A., 2009. Optimal drug combinations and minimal hitting sets. BMC Syst Biol 3, 81. DOI= http://dx.doi.org/10.1186/1752-0509-3-81.
    • (2009) BMC Syst Biol , vol.3 , pp. 81
    • Vazquez, A.1
  • 9
    • 79960047322 scopus 로고    scopus 로고
    • Simulating quantitative cellular responses using asynchronous threshold Boolean network ensembles
    • JACK, J., WAMBAUGH, J.F., and SHAH, I., 2011. Simulating quantitative cellular responses using asynchronous threshold Boolean network ensembles. BMC Syst Biol 5, 109. DOI= http://dx.doi.org/10.1186/1752-0509-5-109.
    • (2011) BMC Syst Biol , vol.5 , pp. 109
    • Jack, J.1    Wambaugh, J.F.2    Shah, I.3
  • 10
    • 79959473110 scopus 로고    scopus 로고
    • An enhanced Petri-net model to predict synergistic effects of pairwise drug combinations from gene microarray data
    • (Jul 1)
    • JIN, G., ZHAO, H., ZHOU, X., and WONG, S.T., 2011. An enhanced Petri-net model to predict synergistic effects of pairwise drug combinations from gene microarray data. Bioinformatics 27, 13 (Jul 1), i310-316. DOI= http://dx.doi.org/10.1093/bioinformatics/btr202.
    • (2011) Bioinformatics , vol.27 , Issue.13
    • Jin, G.1    Zhao, H.2    Zhou, X.3    Wong, S.T.4
  • 12
    • 78649842241 scopus 로고    scopus 로고
    • Genomics, type 2 diabetes, and obesity
    • Dec 9
    • MCCARTHY, M.I., 2010. Genomics, type 2 diabetes, and obesity. N Engl J Med 363, 24 (Dec 9), 2339-2350. DOI= http://dx.doi.org/10.1056/NEJMra0906948.
    • (2010) N Engl J Med , vol.363 , Issue.24 , pp. 2339-2350
    • McCarthy, M.I.1
  • 16
    • 20144385752 scopus 로고    scopus 로고
    • Rule-based modeling of biochemical networks
    • FAEDER, J.R., BLINOV, M.L., GOLDSTEIN, B., and HLAVACEK, W.S., 2005. Rule-based modeling of biochemical networks. Complexity 10, 4, 22-41. DOI= http://dx.doi.org/10.1002/cplx.20074.
    • (2005) Complexity , vol.10 , Issue.4 , pp. 22-41
    • Faeder, J.R.1    Blinov, M.L.2    Goldstein, B.3    Hlavacek, W.S.4
  • 18
    • 0034699781 scopus 로고    scopus 로고
    • A model of beta-cell mass, insulin, and glucose kinetics: Pathways to diabetes
    • Oct 21
    • TOPP, B., PROMISLOW, K., DEVRIES, G., MIURA, R.M., and FINEGOOD, D.T., 2000. A model of beta-cell mass, insulin, and glucose kinetics: pathways to diabetes. J Theor Biol 206, 4 (Oct 21), 605-619. DOI= http://dx.doi.org/10.1006/ jtbi.2000.2150.
    • (2000) J Theor Biol , vol.206 , Issue.4 , pp. 605-619
    • Topp, B.1    Promislow, K.2    Devries, G.3    Miura, R.M.4    Finegood, D.T.5
  • 20
    • 79551587720 scopus 로고    scopus 로고
    • Cytoscape 2.8: New features for data integration and network visualization
    • Feb 1
    • SMOOT, M.E., ONO, K., RUSCHEINSKI, J., WANG, P.L., and IDEKER, T., 2011. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27, 3 (Feb 1), 431-432. DOI= http://dx.doi.org/10.1093/ bioinformatics/btq675.
    • (2011) Bioinformatics , vol.27 , Issue.3 , pp. 431-432
    • Smoot, M.E.1    Ono, K.2    Ruscheinski, J.3    Wang, P.L.4    Ideker, T.5
  • 21
    • 0035374524 scopus 로고    scopus 로고
    • The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes
    • CHIASSON, J.L. and NADITCH, L., 2001. The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes. Diabetes Care 24, 6 (Jun), 989-994.
    • (2001) Diabetes Care , vol.24 , Issue.6 , pp. 989-994
    • Chiasson, J.L.1    Naditch, L.2
  • 22
    • 60249095597 scopus 로고    scopus 로고
    • Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetes
    • ISRAEL, M.K., ISTVAN, E., and BARON, M.A., 2008. Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetes. Vasc Health Risk Manag 4, 6, 1167-1178.
    • (2008) Vasc Health Risk Manag , vol.4 , Issue.6 , pp. 1167-1178
    • Israel, M.K.1    Istvan, E.2    Baron, M.A.3
  • 23
    • 34548311750 scopus 로고    scopus 로고
    • Effects of pioglitazone in combination with metformin or a sulfonylurea compared to a fixed-dose combination of metformin and glibenclamide in patients with type 2 diabetes
    • Aug
    • COMASCHI, M., DEMICHELI, A., DI PIETRO, C., BELLATRECCIA, A., and MARIZ, S., 2007. Effects of pioglitazone in combination with metformin or a sulfonylurea compared to a fixed-dose combination of metformin and glibenclamide in patients with type 2 diabetes. Diabetes Technol Ther 9, 4 (Aug), 387-398. DOI= http://dx.doi.org/10.1089/dia.2006.0023.
    • (2007) Diabetes Technol Ther , vol.9 , Issue.4 , pp. 387-398
    • Comaschi, M.1    Demicheli, A.2    Pietro, C.D.I.3    Bellatreccia, A.4    Mariz, S.5
  • 24
    • 84860430319 scopus 로고    scopus 로고
    • Discovering context-specific relationships from biological literature by using multi-level context terms
    • LEE, S., CHOI, J., PARK, K., SONG, M., and LEE, D., 2012. Discovering context-specific relationships from biological literature by using multi-level context terms. BMC Medical Informatics and Decision Making 12, Suppl 1, S1.
    • (2012) BMC Medical Informatics and Decision Making , vol.12 , Issue.SUPPL. 1
    • Lee, S.1    Choi, J.2    Park, K.3    Song, M.4    Lee, D.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.